OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production utilizes Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex biologics. Optimizing these processes involves adjusting various variables, including cell line selection, media ingredients, and bioreactor conditions. A key goal is to increase antibody yield while reducing production costs a